Skip to main content

Hospital & Laboratory

bioMérieux aims to advance the impact of Clinical Diagnostic in Healthcare by effectively developing and delivering to the market innovative solutions that address significant unmet operational and medical needs, contributing to fight the rise of antimicrobial resistance and to better manage acute conditions linked to infections.

We develop equipment, tests and software that deliver rapid, high-impact, actionable results in immunoassays, microbiology and molecular biology.

Thanks to our "solutions" approach, we take care to always put the patient's interest first by providing our customers with increasingly integrated solutions for optimal workflow and time to result.

In Hospital / In Lab

Patient Conditions 

Antimicrobial Resistance

Antimicrobial Resistance is undermining modern medicine and putting patients at risk of premature death. bioMérieux is committed to preserving antibiotic efficacy with the right diagnostic tests that guide appropriate and responsible use of antibiotics to ensure they remain lifesaving for posterity.

COVID-19/SARS-CoV-2

Because every COVID-19 patient comes with a unique profile and experiences the disease differently, patient management means asking the right questions, finding the right answers and providing appropriate care the entire length of the patient pathway.

Sepsis Solutions 

Early detection and specific clinical intervention has been shown to be crucial for the improved outcome of patients with sepsis. However, sepsis can be difficult to distinguish from other, non-infectious conditions in critically ill patients. bioMérieux provides solutions to help clinicians diagnose and assess sepsis risk as quickly and accurately as possible.

Speciality 

Connectivity and Data

Decision-making can be based on facts and figures that are easily available when needed, to measurably improve the quality, safety, efficiency, and cost of patient care.

Total Service Solutions

At bioMérieux, we understand that ongoing management of a diagnostics platform in the clinical laboratory or in clinic-based settings is no mean feat. That’s why we aim to provide easy access to information and resources to help customers use our products and services with confidence.

This is not our complete list of products and solutions. To view the entire catalogue, please visit biomereiux-usa.com, or press the button below.


Products

Clear All
  • MAESTRIA™

    New Generation Microbiology Middleware

    An innovative, integrated software solution designed to orchestrate your lab routine and transform data into insights.

  • PREVI® COLOR GRAM

    A Market-Leading Automated Gram Stainer Offering Confidence in Results

    Gram staining is a key step in your microbiology workflow, and PREVI® COLOR GRAM is the system to streamline it and provide timely staining results for impactful decisions.

  • RAPIDEC® CARBA NP

    Rapid, Reliable Test for Carbapenemase-Producing Bacteria

    This test gives reliable results in under 2 hours, making it the quick and easy way to control carbapenemase producers and meet diagnostic and screening challenges, improve patient management, and control healthcare associated infections.

  • VIDAS® 3

    Trusted. Robust. Innovative.

    With its advanced immunoassay technology and optimized testing protocols, the fully automated VIDAS® 3 benchtop immunoanalyzer empowers your lab with confidence, offering the precise results you need, when you need them. 

  • VIDAS® D-DIMER EXCLUSION™ II

    Safe Exclusion of Venous Thromboembolism

    VIDAS® D-Dimer Exclusion™ II is a highly-sensitive automated D-Dimer assay. Used in conjunction with assessment of clinical pretest probability, it allows safe exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE) in both low and intermediate suspected outpatient risk groups in just 20 minutes.

  • VIDAS® NEPHROCHECK® [TIMP-2 • IGFBP-7]

    Reveal Kidney Stress Early. Drive Better Outcomes.

    VIDAS® NEPHROCHECK® measures urinary TIMP-2 & IGFBP-7, specific urinary biomarkers for early risk assessment of moderate to severe Acute Kidney Injury (AKI). The VIDAS® NEPHROCHECK® assay is intended to be used in conjunction with clinical evaluation as an aid in the risk assessment for moderate or severe acute kidney injury (AKI) in acutely ill patients.

  • VIDAS® B•R•A•H•M•S PCT™

    Important Biomarker for Improved Patient Management

    Detects procalcitonin, a biomarker that aids in the risk assessment for progression to severe sepsis and septic shock. PCT also aids in decision making on antibiotic therapy for patients with lower respiratory tract infections (LRTI).

  • VILINK®

    Optimize Instrument UPTIME to Improve Laboratory Productivity

    A secure solution offering remote access, proactive maintenance, and remote updates. VILINK® diagnoses, solves software and instrument issues, and supports your systems to enable laboratory productivity and efficiency improvements. 

  • VITEK® 2

    Fully integrated Identification and Antimicrobial Susceptibility Testing

    VITEK® 2, the leading automated system for routine antimicrobial susceptibility testing, provides efficient workflow, faster AST results. Its fully-integrated ID & AST approach ensures superior performance to rapidly and confidently guide therapy.

  • VITEK® MS PRIME

    New-Generation Mass Spectrometry Microbial Identification System

    VITEK® MS PRIME combines microbiology expertise with innovation taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care. 

  • WASP®: Walk Away Specimen Processor

    Automated Microbiology Specimen Processing Instrument

    Quality diagnostic results depend on high standard specimen processing. WASP® is the smart solution for truly comprehensive automation – taking you far beyond plating and streaking to address all aspects of microbiology specimen processing.

    WASP® System is manufactured by COPAN Company.